Podcast
Questions and Answers
Which of the following statements about Budesonide is true?
Which of the following statements about Budesonide is true?
- It is more effective than prednisolone in producing clinical remission in IBD
- It is a synthetic analog of hydrocortisone
- It is released entirely in the colon (correct)
- It has high oral bioavailability due to significant hepatic metabolism
What is the goal of using hydrocortisone enemas in the treatment of inflammatory bowel disease (IBD)?
What is the goal of using hydrocortisone enemas in the treatment of inflammatory bowel disease (IBD)?
- To maintain disease remission by acting on the intestine
- To improve quality of life by reducing fatigue and depression
- To induce remission by suppressing inflammation
- To prevent flare-ups by targeting specific areas of inflammation (correct)
Why should glucocorticoids not be used for maintaining remission in IBD?
Why should glucocorticoids not be used for maintaining remission in IBD?
- They should not be used due to their risk of significant side effects increasing with prolonged use (correct)
- They have low risk of significant side effects with prolonged use
- They have proven efficacy in maintaining remission
- They are more effective than immunomodulators or biologics
What role do glucocorticoids like hydrocortisone play in the treatment of IBD?
What role do glucocorticoids like hydrocortisone play in the treatment of IBD?
What is a common adverse effect associated with the long-term use of glucocorticoids in IBD treatment?
What is a common adverse effect associated with the long-term use of glucocorticoids in IBD treatment?
How does Budesonide differ from traditional corticosteroids in the treatment of IBD?
How does Budesonide differ from traditional corticosteroids in the treatment of IBD?
Which alternative treatment for IBD involves a combination with anti-TNF therapy and has synergistic anti-inflammatory activity?
Which alternative treatment for IBD involves a combination with anti-TNF therapy and has synergistic anti-inflammatory activity?
Which of the following is a common side effect associated with glucocorticoid use in IBD treatment?
Which of the following is a common side effect associated with glucocorticoid use in IBD treatment?
What role do purine analogs play in the treatment of IBD?
What role do purine analogs play in the treatment of IBD?
In cases where patients do not respond well to traditional IBD treatments, which alternative therapy might be considered?
In cases where patients do not respond well to traditional IBD treatments, which alternative therapy might be considered?
What is the median time to clinical response with chronic administration of infliximab for moderate to severe Crohn disease?
What is the median time to clinical response with chronic administration of infliximab for moderate to severe Crohn disease?
What is the main purpose of anti-integrin agents in the treatment of inflammatory bowel disease (IBD)?
What is the main purpose of anti-integrin agents in the treatment of inflammatory bowel disease (IBD)?
Which statement about the side effects of glucocorticoids in IBD treatment is true?
Which statement about the side effects of glucocorticoids in IBD treatment is true?
What is the approved dosing regimen for infliximab in the maintenance of remission for Crohn’s disease?
What is the approved dosing regimen for infliximab in the maintenance of remission for Crohn’s disease?
What is the main goal of using hydrocortisone enemas in the treatment of IBD?
What is the main goal of using hydrocortisone enemas in the treatment of IBD?
What is the FDA-approved glucocorticoid for the treatment of moderate to severe IBD?
What is the FDA-approved glucocorticoid for the treatment of moderate to severe IBD?
How long does it generally take for improvement to occur in most patients with Crohn’s disease after initiating glucocorticoid treatment?
How long does it generally take for improvement to occur in most patients with Crohn’s disease after initiating glucocorticoid treatment?
What is the preferred route of administration for active cases of IBD in the rectum and sigmoid colon?
What is the preferred route of administration for active cases of IBD in the rectum and sigmoid colon?
What are some serious side effects associated with glucocorticoids in the treatment of IBD?
What are some serious side effects associated with glucocorticoids in the treatment of IBD?
Why is maintenance treatment with systemic glucocorticoids not recommended?
Why is maintenance treatment with systemic glucocorticoids not recommended?
What is the mechanism of action of Vedolizumab (VDZ) in treating intestinal lesions?
What is the mechanism of action of Vedolizumab (VDZ) in treating intestinal lesions?
Which therapy is considered a second-line treatment for patients with moderate to severe Crohn’s Disease who have failed other therapies?
Which therapy is considered a second-line treatment for patients with moderate to severe Crohn’s Disease who have failed other therapies?
What is a common adverse effect associated with Vedolizumab (VDZ) treatment?
What is a common adverse effect associated with Vedolizumab (VDZ) treatment?
Which statement is true regarding the administration of Ustekinumab?
Which statement is true regarding the administration of Ustekinumab?
What is the primary goal of using anti-Integrin agents in the treatment of inflammatory bowel disease (IBD)?
What is the primary goal of using anti-Integrin agents in the treatment of inflammatory bowel disease (IBD)?
What is the mechanism of action of anti-integrin agents in the treatment of inflammatory bowel disease (IBD)?
What is the mechanism of action of anti-integrin agents in the treatment of inflammatory bowel disease (IBD)?
Which anti-IBD drug is classified as an Anti-IL-12/23 Therapy?
Which anti-IBD drug is classified as an Anti-IL-12/23 Therapy?
What is a significant adverse effect associated with Vedolizumab (VDZ) therapy?
What is a significant adverse effect associated with Vedolizumab (VDZ) therapy?
Which of the following statements about Ustekinumab is true?
Which of the following statements about Ustekinumab is true?
What potential outcome is observed when infliximab therapy is discontinued, even after prolonged remission?
What potential outcome is observed when infliximab therapy is discontinued, even after prolonged remission?
What is the black box warning issued by the FDA in 2019 regarding Tofacitinib (Xeljanz)?
What is the black box warning issued by the FDA in 2019 regarding Tofacitinib (Xeljanz)?
What is a recommended precaution before starting treatment with Tofacitinib (Xeljanz) to reduce the risk of herpes zoster reactivation?
What is a recommended precaution before starting treatment with Tofacitinib (Xeljanz) to reduce the risk of herpes zoster reactivation?
Which interleukins involved in mucosal inflammation are influenced by interruption of the signaling pathway by certain medications?
Which interleukins involved in mucosal inflammation are influenced by interruption of the signaling pathway by certain medications?
What is a significant reason why Tofacitinib (Xeljanz) should not be taken concurrently with other immunosuppressants?
What is a significant reason why Tofacitinib (Xeljanz) should not be taken concurrently with other immunosuppressants?
At what point is it recommended to discontinue Tofacitinib (Xeljanz) if there is no response observed?
At what point is it recommended to discontinue Tofacitinib (Xeljanz) if there is no response observed?
Which medication is classified as an anti-IL-12/23 therapy for the treatment of Inflammatory Bowel Disease?
Which medication is classified as an anti-IL-12/23 therapy for the treatment of Inflammatory Bowel Disease?
What is a potential adverse effect associated with Vedolizumab (VDZ) therapy in the treatment of IBD?
What is a potential adverse effect associated with Vedolizumab (VDZ) therapy in the treatment of IBD?
Which of the following medications is an Alpha-4 integrin inhibitor used in the treatment of Inflammatory Bowel Disease?
Which of the following medications is an Alpha-4 integrin inhibitor used in the treatment of Inflammatory Bowel Disease?
What is one of the goals of using Anti-Integrin agents in the treatment of Inflammatory Bowel Disease?
What is one of the goals of using Anti-Integrin agents in the treatment of Inflammatory Bowel Disease?
Which biologic therapy aims for inhibition of interleukins 12 and 23 in patients with Inflammatory Bowel Disease?
Which biologic therapy aims for inhibition of interleukins 12 and 23 in patients with Inflammatory Bowel Disease?
What is the main reason behind Vedolizumab (VDZ) having little systemic immunosuppression?
What is the main reason behind Vedolizumab (VDZ) having little systemic immunosuppression?
Which therapy is considered a second-line treatment for moderate to severe Crohn’s Disease patients who have not responded to other treatments?
Which therapy is considered a second-line treatment for moderate to severe Crohn’s Disease patients who have not responded to other treatments?
What is a common adverse effect associated with the Ustekinumab therapy for Crohn’s Disease?
What is a common adverse effect associated with the Ustekinumab therapy for Crohn’s Disease?
How does Vedolizumab (VDZ) achieve its therapeutic effects in treating intestinal lesions?
How does Vedolizumab (VDZ) achieve its therapeutic effects in treating intestinal lesions?
Which medication acts by blocking cell signaling, cytokine production, and gene activation, resulting in the inhibition of cell-mediated responses important in inflammation of Crohn’s disease?
Which medication acts by blocking cell signaling, cytokine production, and gene activation, resulting in the inhibition of cell-mediated responses important in inflammation of Crohn’s disease?
Which of the following is a potential outcome when patients discontinue Vedolizumab therapy for inflammatory bowel disease?
Which of the following is a potential outcome when patients discontinue Vedolizumab therapy for inflammatory bowel disease?
What is a common adverse effect associated with the long-term use of Vedolizumab (VDZ) in the treatment of inflammatory bowel disease?
What is a common adverse effect associated with the long-term use of Vedolizumab (VDZ) in the treatment of inflammatory bowel disease?
In the treatment of inflammatory bowel disease, which therapy aims to inhibit interleukins 12 and 23?
In the treatment of inflammatory bowel disease, which therapy aims to inhibit interleukins 12 and 23?
What is one of the notable adverse effects associated with Vedolizumab therapy in the treatment of inflammatory bowel disease?
What is one of the notable adverse effects associated with Vedolizumab therapy in the treatment of inflammatory bowel disease?
Which therapy blocks the action of integrins in the treatment of inflammatory bowel disease?
Which therapy blocks the action of integrins in the treatment of inflammatory bowel disease?
What is the mechanism of action of Vedolizumab (VDZ) in the treatment of inflammatory bowel disease?
What is the mechanism of action of Vedolizumab (VDZ) in the treatment of inflammatory bowel disease?
Which of the following is a common adverse effect associated with Vedolizumab (VDZ) therapy in the treatment of inflammatory bowel disease?
Which of the following is a common adverse effect associated with Vedolizumab (VDZ) therapy in the treatment of inflammatory bowel disease?
What is one of the goals of using anti-Integrin agents in the treatment of inflammatory bowel disease (IBD)?
What is one of the goals of using anti-Integrin agents in the treatment of inflammatory bowel disease (IBD)?
Which medication is classified as an Anti-IL-12/23 Therapy for the treatment of inflammatory bowel disease?
Which medication is classified as an Anti-IL-12/23 Therapy for the treatment of inflammatory bowel disease?
What is a significant adverse effect associated with Vedolizumab (VDZ) therapy in the treatment of inflammatory bowel disease?
What is a significant adverse effect associated with Vedolizumab (VDZ) therapy in the treatment of inflammatory bowel disease?
Flashcards are hidden until you start studying
